Biopharma – CrispIdea

Biopharma

All
Biopharma

June 19, 2019

AbbVie Inc (ABBV) – AbbVie showing progress in its pipeline by approval of SKYRIZI

AbbVie’s revenues declined by 1.3% to $7.83bn in Q1FY19 and increased by 0.4% operationally. The revenues declined due to a decrease in HUMIRA international revenues due to the biosimilar competition. However, HUMIRA revenues from the U.S. increased by 7.1% to $3.2bn in Q1FY19 and will not face biosimilar competition in the U.S. until FY23. Number […]

June 11, 2019

Biogen Inc (BIIB) – Strong operational performance in MS, SMA and Biosimilar Franchises

Biogen delivered strong financial results during the quarter due to the strong operational performance of the MS, SMA, and biosimilars franchises. Total revenues increased by 11% to $3.5bn and adjusted EPS increased by 15% to $6.98 for Q1FY19. Number of Pages – 47 Contents Executive Summary Financial Statements –Income Statement and Forecast –Balance Sheet –Cash […]